$6.29
-0.54-7.97%
At close: Aug 21, 5:00 PM EST
$6.38
0.091.43%
After Hours: Aug 21, 7:59 PM EST
Capricor Therapeutics Inc Earnings Estimates
CAPRNASDAQ
Capricor Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CAPR
Capricor Therapeutics (CAPR) is scheduled to report Q3 earnings on November 9, 2026. Analysts estimate EPS of $-0.43 and quarterly revenue of $10.4M.
In the most recent quarter (Q2), Capricor Therapeutics reported EPS of $-0.7, missing estimates of $-0.58 by 0.21%. Revenue came in at $0, meeting the estimate of $0 by 0%.
Capricor Therapeutics has missed EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Capricor Therapeutics has averaged an EPS surprise of 0.12% and a revenue surprise of 1%.
Earnings Date
Nov 9
EPS Estimate
$-0.430
Quarterly Revenue Estimate
$10.4M
Annual Revenue
–
as of Jun 30
Capricor Therapeutics Earnings History
Analyze the earnings history of Capricor Therapeutics using advanced sorting and filters.
Capricor Therapeutics (CAPR) Earnings Per Share
The chart below shows Capricor Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Capricor Therapeutics (CAPR) Revenue
The chart below shows Capricor Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?
Capricor Therapeutics (CAPR) is scheduled to report earnings on November 9, 2026. The last reported earnings were for reported on August 13, 2026 for Q2.
What were the latest earnings per share (EPS) for Capricor Therapeutics (NASDAQ:CAPR)?
The Actual EPS was $-0.7, which missed the estimate of $-0.58.
What were Capricor Therapeutics’s (NASDAQ:CAPR) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
